REG - Feedback PLC - Confirmation of CFO Board Appointment

FeedbackAnnouncement

Mon 16:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260216:nRSP2263Ta&default-theme=true

RNS Number : 2263T  Feedback PLC  16 February 2026

 

Feedback plc

 

Directorate Change

 

Confirmation of CFO Board Appointment

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical
infrastructure specialist, confirms that further to the announcement of 20
October 2025, that Chief Financial Officer ("CFO") Emma Oswick (Stuart) has
been appointed to the Company's Board of Directors, effective from today.

 

Emma joined the Company in November 2025
(https://www.londonstockexchange.com/news-article/FDBK/directorate-change/17285233)
, bringing a background of extensive experience in subscription-led technology
businesses, having most recently served as Interim CFO at Energy Aspects. She
is passionate about the sector and technology's role in process improvement
and positioning for growth. Emma has a proven track record in driving
strategic change, optimising financial performance, and developing
high-performing teams. She also has considerable M&A and integration
experience and is a Chartered Accountant, having qualified with PwC.

 

Further Information:

The following additional information is provided in accordance with Rule 17
and Schedule Two Paragraph (g) of the AIM Rules for Companies:

 

Emma Jane Stuart (née Oswick), aged 54, holds or has held the following
directorships in the last five years:

 

 Current directorships             Past directorships within the last five years
 Osmia Consulting Limited          Dynata Global UK Ltd
 Argentis Properties Limited       E-Rewards Bidco Limited
 Chartered Institute of Marketing

 

Save for the information disclosed above, there is no other information in
relation to Emma Oswick that is required to be disclosed pursuant to Rule 17
and Schedule Two paragraph (g) of the AІM Rules for Companies.

 

Dr Tom Oakley, CEO of Feedback plc, said: "We are delighted to confirm Emma's
position on the Board. She has fully immersed herself in Feedback since
joining in November with her input and direction further strengthening our
capabilities at this critical stage of the Company's evolution - with Bleepa
strongly positioned to fulfil the growing requirements for innovative
solutions as the healthcare system and government spending focus on digital
transformation."

 

--Ends--

Enquiries:

 

 Feedback plc                                +44 (0) 20 3997 7634

 Tom Oakley, CEO                             IR@fbk.com (mailto:IR@fbk.com)

 Emma Oswick, CFO

 Panmure Liberum Limited (NOMAD and Broker)  +44 (0)20 7886 2500

 Emma Earl/Mark Rogers (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd;                            Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                             (mailto:feedbackplc@walbrookpr.com)
 Nick Rome/Marcus Ulker                      07748 325 236 or 07867 984 082

 

 

About Feedback plc

 

Feedback plc is the strategic partner to unlock productivity in health and
care through digital connectivity and asynchronous collaboration. With proven
expertise in system integration, we enable teams to work flexibly, share
information securely, and deliver care more efficiently.

 

Bleepa® is an award-winning collaboration platform that improves the quality
and productivity of patient pathways enabling health and care organisations to
hit targets with their existing clinical workforce. We achieve this by
connecting digital infrastructure across systems, enabling asynchronous
working, reducing geographic barriers and removing unnecessary appointments.

 

Bleepa supports the shift from analogue to digital and from hospital to
community-based care, by uniting essential data and teams to enhance clinical
decision making and enable better coordinated care.

 

The Company has a number of growth opportunities domestically and
internationally across a range of public and private healthcare markets
including the NHS. Our highly scalable software-as-a-service (SaaS) based
model is expected to provide increasing levels of revenue visibility as the
Company grows its customer base.

 

https://fbk.com (https://fbk.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOATFMFTMTJBBMF



            Copyright 2019 Regulatory News Service, all rights reserved